Clinical Trial

Clinical Trial of Subunit Influenza Vaccine (Adjuvant) in Chinese Population Aged 65 Years and Older

Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The objective of this study was to evaluate the safety of subunit influenza vaccine (adjuvant) in people aged 65 years and older.
Trial Details
NCT Number NCT07421050
Lead Sponsor Ab&B Bio-tech Co., Ltd.JS
Collaborators: Yither Biotech Co., Ltd
Conditions Influenza, Influenza Vaccine
Enrollment 80 participants
Start Date 2025-11-13
Primary Completion 2026-12-13 (estimated)
Study Completion 2026-12-13 (estimated)
Updated on ClinicalTrials.gov 2026-02-19